Nitroglycerin Infusion Dosing and Contraindications
Intravenous Nitroglycerin Dosing Protocol
Start IV nitroglycerin at 10 µg/min when using non-absorbing tubing, then titrate by 10 µg/min every 3–5 minutes until symptom relief or blood pressure response is achieved. 1
Initial Dosing Strategy
The American Heart Association and American College of Cardiology recommend starting at 10 µg/min with non-absorbing tubing, which is lower than the 25 µg/min used in older studies that employed PVC tubing (PVC absorbs nitroglycerin, requiring higher doses). 1, 2
The FDA label specifies that when using non-absorbing infusion sets, the initial dose should be 5 µg/min, though guideline consensus favors 10 µg/min as the practical starting point. 2
Titrate by 10 µg/min increments every 3–5 minutes until you observe symptom relief or blood pressure response. 1
Escalation Protocol
If no response occurs at 20 µg/min, continue with 10 µg/min increments; once you reach higher doses without effect, switch to 20 µg/min increments. 1
Once partial blood pressure response is observed, reduce the size of dose increases and lengthen the interval between titrations to avoid overshooting and causing hypotension. 1, 2
The practical ceiling is 200 µg/min, though doses up to 300–400 µg/min have been shown safe in clinical studies. 1
The maximum concentration should not exceed 400 µg/mL when preparing dilutions to limit fluid administration. 2
Special Populations
- Patients with normal or low left ventricular filling pressures (e.g., uncomplicated angina) may be hypersensitive and respond fully to doses as low as 5 µg/min, requiring especially careful titration and monitoring. 2
Critical Administration Requirements
IV nitroglycerin must be delivered through non-absorbing tubing using an infusion pump; PVC tubing absorbs significant amounts of the drug, making dosing unpredictable. 1, 2
The drug must be diluted in either 5% dextrose or 0.9% sodium chloride before infusion—never give as direct IV injection. 2
Standard dilution is 50 mg nitroglycerin in 500 mL (yielding 100 µg/mL) or 5 mg in 100 mL (yielding 50 µg/mL). 2
If you change the concentration, you must flush or replace the infusion set before the new concentration is used, otherwise it may take minutes to hours for the new concentration to reach the patient depending on flow rate and tubing dead space. 2
Absolute Contraindications
Never administer nitroglycerin within 24 hours of sildenafil or vardenafil, within 48 hours of tadalafil, or within 12 hours of avanafil due to risk of fatal hypotension. 1, 3, 4
PDE5 Inhibitor Timing
The American Heart Association and American College of Cardiology mandate querying every chest pain patient about erectile dysfunction medication use; concurrent use with nitrates can be lethal. 1
Document PDE5 inhibitor use and exact timing in every chest pain evaluation before administering any form of nitroglycerin. 1
Blood Pressure Thresholds
Do not give nitroglycerin if systolic blood pressure (SBP) is <90 mmHg or if SBP would drop ≥30 mmHg below the patient's baseline. 1, 3
For normotensive patients, do not reduce SBP below 110 mmHg during IV therapy. 1
Right Ventricular Infarction
Right ventricular infarction is an absolute contraindication because these patients are preload-dependent; nitroglycerin causes dangerous preload reduction. 1, 3, 4
The American College of Cardiology advises obtaining right-sided ECG leads (V4R) in all inferior STEMI patients before giving nitrates; withhold if RV involvement is evident. 1
Heart Rate Extremes
Avoid nitroglycerin in extreme bradycardia (heart rate <50 bpm) due to risk of worsening bradycardia. 3
Avoid in tachycardia >100 bpm unless heart failure is present, as nitroglycerin may worsen tachycardia. 3
Tolerance Development
Continuous nitroglycerin exposure beyond 7–8 hours leads to tolerance, requiring either dose escalation or a nitrate-free interval. 1
Tolerance may develop after 7–8 hours of continuous IV infusion, potentially necessitating dose increases to maintain effect. 1
A daily nitrate-free interval of 10–12 hours prevents tolerance when using transdermal patches or long-acting oral nitrates. 1
Transdermal patches (0.2–0.8 mg/hour) must be removed after 12 hours and reapplied after a 12-hour nitrate-free period to maintain efficacy. 1
Monitoring Requirements
Continuous monitoring of blood pressure and heart rate is mandatory during IV nitroglycerin infusion; measure pulmonary capillary wedge pressure when appropriate. 2
There is no fixed optimal dose—each patient must be titrated to the desired hemodynamic endpoint based on continuous physiologic monitoring. 2
Adequate systemic blood pressure and coronary perfusion pressure must be maintained throughout the infusion. 2
Hypotension requiring vasopressors occurs in approximately 4% of patients receiving high-dose infusions (≥100 µg/min), though this rate is not significantly different from lower doses. 5, 6
Clinical Indications
Primary indications are acute angina relief, unstable angina/NSTEMI with ongoing ischemia, and acute decompensated heart failure with hypertension. 1
Transition to IV nitroglycerin when symptoms persist after three sublingual doses (0.4 mg every 5 minutes) in unstable angina/NSTEMI. 1
In hypertensive acute coronary syndrome, IV nitroglycerin serves dual purposes: blood pressure control and ischemia relief. 1
For sympathetic crashing acute pulmonary edema (SCAPE), high-dose IV nitroglycerin (≥100 µg/min) reduces time to oxygen weaning (median 2.7 hours vs 3.3 hours with low-dose) and increases likelihood of achieving 25% SBP reduction within 60 minutes. 6, 7